M&A Deal Summary

Pharos Capital Group Acquires RhythMedix

On January 4, 2024, private equity firm Pharos Capital Group acquired medical products company RhythMedix

Acquisition Highlights
  • This is Pharos Capital Group’s 4th transaction in the Medical Products sector.
  • This is Pharos Capital Group’s 38th transaction in the United States.
  • This is Pharos Capital Group’s 1st transaction in New Jersey.

M&A Deal Summary

Date 2024-01-04
Target RhythMedix
Sector Medical Products
Buyer(s) Pharos Capital Group
Deal Type Buyout (LBO, MBO, MBI)

Target

RhythMedix

Mt. Laurel, New Jersey, United States
RhythMedix is a medical device manufacturer and wireless medical technology company, that provides innovative technology to transform cardiac monitoring industry and improve patient outcomes. It is first wearable cardiac monitor with built-in cellular connectivity, allowing physicians and their patients to remain continuously and comfortably connected for faster arrhythmia detection. RhythMedix was founded in 2013 and is based in Mt. Laurel, New Jersey.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Pharos Capital Group

Dallas, Texas, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1998
PE ASSETS 1.0B USD
Size Middle-Market
Type Sector Focused
DESCRIPTION

Pharos Capital Group is a private equity firm that provides later-stage equity funding to companies at or near cash-flow break even. Investment funds are typically used to support growth, acquisitions, management buyouts, or recapitalization. Pharos looks to commit $20 to $50 million per transaction. Target sectors include healthcare, business services, and technology. Pharos prefers US-based opportunities. Pharos Capital Group was formed in 1998 and is based in Dallas, Texas.


DEAL STATS #
Overall 39 of 39
Sector (Medical Products) 4 of 4
Type (Buyout (LBO, MBO, MBI)) 18 of 18
State (New Jersey) 1 of 1
Country (United States) 38 of 38
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-02-01 MOTION PT Group

New York, New York, United States

MOTION PT Group is a provider of physical and occupational therapy services. Its comprehensive service offerings include specialized treatment in orthopedics, sports medicine, hand, and upper extremity, spine, hip, pediatrics, lymphedema, men's/women's health, vestibular rehabilitation, neurological rehabilitation, diabetic neuropathy, and aquatic therapy. MOTION PT Group was formed in 2015 and is based in New York City.

Sell -